Full data view for gene CERKL


This database is one of the ”Retinal and hearing impairment genetic variant databases”.
Information The variants shown are described using the transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/. - c.356G>A r.(?) p.(Gly119Asp) Parent #1 - likely pathogenic (recessive) g.182468689C>T g.181603962C>T 356C>T - CERKL_000080 - PubMed: Weisschuh 2016 - - Germline - - - - - DNA SEQ-NG - gene panel retinal disease RCD117 PubMed: Weisschuh 2016 family - - Germany - - - - - 1 LOVD
+?/. - c.356G>A r.(?) p.(Gly119Asp) Unknown - likely pathogenic g.182468689C>T g.181603962C>T NM_001030311.2, c.356G>A, p.Gly119Asp - CERKL_000080 - PubMed: Ezquerra-Inchausti 2018 - - Germline ? - - - - DNA SEQ-NG blood - retinal disease ? PubMed: Ezquerra-Inchausti 2018 Family RP169 ? ? Spain - - - - - 1 LOVD
+?/. - c.356G>A r.(?) p.(Gly119Asp) Both (homozygous) ACMG likely pathogenic g.182468689C>T g.181603962C>T CERKL c.356G>A, p.(Gly119Asp) - CERKL_000080 homozygous PubMed: Dineiro 2020 - - Germline ? - - - - DNA SEQ-NG-I, SEQ blood, saliva targeted sequencing with 1 of 4 panels of OFTALMOgenics probes retinal disease OFTALMO.033 PubMed: Dineiro 2020 - ? - Spain - - - - - 1 LOVD
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.